Fig. 4From: Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boardsAnalysis of differing and matched therapy options between molecular tumor boards. The left-sided panel demonstrates the relative frequency of differing therapy options according to the molecular level of supporting biomarkers, the underlying molecular evidence level, and the ten most frequent therapeutic baskets. The corresponding relative frequencies for matched therapy options are shown in the right panelBack to article page